Skip to main content
Premium Trial:

Request an Annual Quote

There's a Whole Lot of Difference in that 0.1 Percent

Robert Lee Hotz writes a science column for the Wall Street Journal about human variation, and some of the latest large-scale studies that have made progress in identifying disease-linked variants. GTO enjoyed his description of the genome: "The human genome is a biomedical narrative of migration, disease, conquest and trade. It has been accumulating plot twists and changes since small clans first moved out of East Africa to settle the world tens of thousands of years ago." In more scientific parts of the essay, Hotz mentions recent studies from Stanford, the University of Michigan, Cornell, and other institutions that have clarified the genetic factors behind a number of diseases.

 

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.